VANOGLIPEL
UNII 6380I4YM3Q

Substance Identification & Data

This profile provides standardized clinical and technical data for Vanoglipel, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6380I4YM3Q.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1914136-10-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

6380I4YM3Q

CAS Registry Number

1914136-10-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VANOGLIPEL

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C25H31F2N5O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

XQSZLXRXPGLHLH-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C224801

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

121304331

Unique identification number in the NCBI database of chemical substances.

INN ID

13923

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NO-42

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1(cc(cc(c1-c2noc(n2)C(C)C)F)OCCCC3CCN(CC3)c4ncc(cn4)CC)F

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Vanoglipel. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.